Ye S - Search Results

1

A Pan-cancer Clinical Study of Personalized Neoantigen Vaccine Monotherapy in Treating Patients with Various Types of Advanced Solid Tumors.

Fang Y, Mo F, Shou J, Wang H, Luo K, Zhang S, Han N, Li H, Ye S, Zhou Z, Chen R, Chen L, Liu L, Wang H, Pan H, Chen S. Fang Y, et al. Among authors: ye s. Clin Cancer Res. 2020 Sep 1;26(17):4511-4520. doi: 10.1158/1078-0432.CCR-19-2881. Epub 2020 May 21. Clin Cancer Res. 2020. PMID: 32439700

2

Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy.

Shou J, Mo F, Zhang S, Lu L, Han N, Liu L, Qiu M, Li H, Han W, Ma D, Guo X, Guo Q, Huang Q, Zhang X, Ye S, Pan H, Chen S, Fang Y. Shou J, et al. Among authors: ye s. Front Immunol. 2022 Sep 29;13:1000681. doi: 10.3389/fimmu.2022.1000681. eCollection 2022. Front Immunol. 2022. PMID: 36248865 Free PMC article. Clinical Trial.

3

Quantitative analysis with multiphase contrast-enhanced computed tomography to evaluate residual tumor activity of hepatocellular carcinoma after DEB-TACE.

Hu W, Cao G, Ye S, Xu J, Chen J, Shao G. Hu W, et al. Among authors: ye s. Medicine (Baltimore). 2023 Jun 16;102(24):e34054. doi: 10.1097/MD.0000000000034054. Medicine (Baltimore). 2023. PMID: 37327303 Free PMC article.

4

A new classification and regression tree algorithm: Improved diagnostic sensitivity for HCC ≤ 3.0 cm using gadoxetate disodium-enhanced MRI.

Pan J, Ye S, Song M, Yang T, Yang L, Zhu Y, Zhao Y, Chen F. Pan J, et al. Among authors: ye s. Eur J Radiol. 2023 May;162:110770. doi: 10.1016/j.ejrad.2023.110770. Epub 2023 Mar 14. Eur J Radiol. 2023. PMID: 36933495

5

Current status and prospect of PET-related imaging radiomics in lung cancer.

Tang X, Wu F, Chen X, Ye S, Ding Z. Tang X, et al. Among authors: ye s. Front Oncol. 2023 Dec 18;13:1297674. doi: 10.3389/fonc.2023.1297674. eCollection 2023. Front Oncol. 2023. PMID: 38164195 Free PMC article. Review.

6

Eosinophilia in a patient with aggressive systemic mastocytosis harboring a KIT D816V mutation: A case report.

Cao L, Tong H, Liu X, Pan Q, Xu Y, Lai J, Zheng W, Huang J, Wang Z, Ye S, Zhang L, Qin J, Jin J. Cao L, et al. Among authors: ye s. SAGE Open Med Case Rep. 2023 Aug 30;11:2050313X231197322. doi: 10.1177/2050313X231197322. eCollection 2023. SAGE Open Med Case Rep. 2023. PMID: 37663152 Free PMC article.

7

Imaging features of retinal hemangioblastoma: A case report.

Tang X, Ji HM, Li WW, Ding ZX, Ye SL. Tang X, et al. World J Clin Cases. 2023 Jan 26;11(3):692-699. doi: 10.12998/wjcc.v11.i3.692. World J Clin Cases. 2023. PMID: 36793647 Free PMC article.

8

RON receptor tyrosine kinase as a critical determinant in promoting tumorigenic behaviors of bladder cancer cells through regulating MMP12 and HIF-2α pathways.

Wang KJ, Ye SZ, Jia XL, Wang KY, Meng XY, Fei X, Ye SJ, Ma Q. Wang KJ, et al. Among authors: ye sz, ye sj. Cell Death Dis. 2024 Nov 19;15(11):844. doi: 10.1038/s41419-024-07245-w. Cell Death Dis. 2024. PMID: 39557851

9

A safe antiparasitic extract from Psoralea corylifolia for Tetrahymeniasis control.

Li Y, Zhou W, Cui Y, Zhou P, Shan Y, Jin N, Ye S. Li Y, et al. Among authors: ye s. Vet Parasitol. 2024 Nov 14;333:110341. doi: 10.1016/j.vetpar.2024.110341. Online ahead of print. Vet Parasitol. 2024. PMID: 39556990

10

Etoposide targets 2A protease to inhibit enterovirus 71 replication.

Liang Q, Shi S, Zhang Q, Wang Y, Ye S, Xu B. Liang Q, et al. Among authors: ye s. Microbiol Spectr. 2024 Nov 18:e0220024. doi: 10.1128/spectrum.02200-24. Online ahead of print. Microbiol Spectr. 2024. PMID: 39555929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,487 results

Search Page

Filters